Kura Oncology, Inc.·4

Jan 24, 4:07 PM ET

GUALBERTO ANTONIO 4

4 · Kura Oncology, Inc. · Filed Jan 24, 2019

Insider Transaction Report

Form 4
Period: 2019-01-22
GUALBERTO ANTONIO
Chief Medical Officer
Transactions
  • Award

    Option to purchase common stock

    2019-01-22+140,000140,000 total
    Exercise: $15.47Exp: 2029-01-21Common Stock (140,000 underlying)
Footnotes (1)
  • [F1]This option vests in 48 equal monthly installments commencing on the grant date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION